Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Go back to Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update| (NASDAQ: VRDN) | Delayed: 22.47 -0.35 (1.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.82 | 52 Week High | $ | |||
| Open | $22.75 | 52 Week Low | $ | |||
| Day High | $22.75 | P/E | N/A | |||
| Day Low | $21.92 | EPS | $ | |||
| Volume | 403,895 | |||||



